| For: | Liu CX, Gao Y, Xu XF, Jin X, Zhang Y, Xu Q, Ding HX, Li BJ, Du FK, Li LC, Zhong MW, Zhu JK, Zhang GY. Bile acids inhibit ferroptosis sensitivity through activating farnesoid X receptor in gastric cancer cells. World J Gastroenterol 2024; 30(5): 485-498 [PMID: 38414591 DOI: 10.3748/wjg.v30.i5.485] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v30/i5/485.htm |
| Number | Citing Articles |
| 1 |
Xiulian Lin, Li Xia, Yuanjiao Zhou, Jingchen Xie, Qinhui Tuo, Limei Lin, Duanfang Liao. Crosstalk Between Bile Acids and Intestinal Epithelium: Multidimensional Roles of Farnesoid X Receptor and Takeda G Protein Receptor 5. International Journal of Molecular Sciences 2025; 26(9) doi: 10.3390/ijms26094240
|
| 2 |
Jiayan Luo, Yuhao Yu, Haojun Song, Bujiang Wang. The Gut Microbiota–Ferroptosis Axis: Emerging Perspectives in Gastrointestinal Tumorigenesis and Progression. Current Issues in Molecular Biology 2025; 47(12) doi: 10.3390/cimb47121025
|
| 3 |
Lin Yang, Jinlian Wang, Xuhui Wang, Bianli Li, Di Zhao, Chunyi Li, Changzhi Li, Yuanbing Cui, Qiuyuan Chen, Yong Yang, Jinhai Gu, Shaozhang Hou, Lianxiang Zhang, Yuanyuan Qiang. Ketogenic diet improves cognitive impairment in rats with temporal lobe epilepsy by activating the Nrf2/HO-1/GPX4 signaling axis to inhibit ferroptosis. Free Radical Biology and Medicine 2026; 246 doi: 10.1016/j.freeradbiomed.2026.01.022
|
| 4 |
Pengzhao Tang, Hui Feng, Dandan Zhang, Jinlu Wu, Yaochuan Zhou, Wuwen Feng, Cheng Peng. Dietary Polyphenols in Metabolic Diseases: Roles of Gut Microbiota‐Derived Metabolites. Phytotherapy Research 2026; 40(3) doi: 10.1002/ptr.70180
|
| 5 |
Yuan-Li Ai, Qiao Wu, Hang-Zi Chen. Nuclear Receptors as Orchestrators of Regulatory Cell Death. Biochemistry 2026; 65(7) doi: 10.1021/acs.biochem.5c00748
|
| 6 |
Na Liu, Jianzeng Zhang, Jiaojiao Wu, Fan Feng, Yantao Chai, Yongwu Li, Bo Liu. Targeting hepatocellular carcinoma growth and metabolism: A synergistic approach with para-toluenesulfonamide and radiofrequency ablation. iLIVER 2024; 3(3) doi: 10.1016/j.iliver.2024.100111
|
| 7 |
Fabrizio Termite, Sebastiano Archilei, Francesca D’Ambrosio, Lucrezia Petrucci, Nicholas Viceconti, Roberta Iaccarino, Antonio Liguori, Antonio Gasbarrini, Luca Miele. Gut Microbiota at the Crossroad of Hepatic Oxidative Stress and MASLD. Antioxidants 2025; 14(1) doi: 10.3390/antiox14010056
|
| 8 |
Yao Lu, Huiping Yuan, Shaojie Liang, Debing Li, Pengfei Jiang, Xian Wang, Ke Zhang, Dechun Liu. Microbial metabolite-driven immune reprogramming in tumor immunotherapy: mechanisms and therapeutic perspectives. Frontiers in Immunology 2025; 16 doi: 10.3389/fimmu.2025.1603658
|
| 9 |
Yuxin Zhang, Yuchao Jing, Juan He, Rui Dong, Tongyang Li, Fang Li, Xiaoqing Zheng, Gaoyu Liu, Ran Jia, Jin Xu, Fan Wu, Chunhong Jia, Jin Song, Lijuan Zhang, Pan Zhou, Haitao Wang, Zhi Yao, Qiang Liu, Ying Yu, Jie Zhou. Bile acid receptor FXR promotes intestinal epithelial ferroptosis and subsequent ILC3 dysfunction in neonatal necrotizing enterocolitis. Immunity 2025; 58(3) doi: 10.1016/j.immuni.2025.02.003
|
| 10 |
Jing Liu, Fuxing Li, Qianru Zeng, Wenxiao Hu, Le Yang, Shengping Luo, Dingxiang Li, Yihui Deng. Dysregulated bile acid metabolism drives lipid peroxidation and ferroptosis in NAFLD: therapeutic potential for traditional Chinese medicine. Frontiers in Pharmacology 2025; 16 doi: 10.3389/fphar.2025.1669805
|
| 11 |
Chenzhe Gao, Jiahui Ma, Yang Yu, Lin Zhang, Yue Pang, Haiyan Zhang, Chenyu Xue, Dehai Li, Xiaoyu Zhao, Munkh-Amgalan Gantumur, Mizhou Hui, Weichen Hong, Yihong Bao, Bailiang Li, Na Dong. The Interplay between Gut Microbiota-Derived Metabolites and Ferroptosis: Implications for Intestinal Health and Disease. Journal of Agricultural and Food Chemistry 2025; 73(23) doi: 10.1021/acs.jafc.5c00130
|
| 12 |
Dominika Stygar, Bartosz Bogielski, Katarzyna Michalczyk, Bronisława Skrzep-Poloczek, Alicja Suchocka, Kamil Nikiel, Kazimierz Kukla, Rafał Wasek, Jakub Staniszewski, Maciej Matyja, Michał Kukla. Cholestatic and autoimmune liver diseases, bile duct injury, oxidative stress, and therapeutic strategies. Frontiers in Physiology 2026; 17 doi: 10.3389/fphys.2026.1788973
|
| 13 |
Youchao Qi, Yonggui Ma, Guozhen Duan. Pharmacological Mechanisms of Bile Acids Targeting the Farnesoid X Receptor. International Journal of Molecular Sciences 2024; 25(24) doi: 10.3390/ijms252413656
|
| 14 |
Weiwei Cui, Meng Hao, Xin Yang, Chengqian Yin, Bo Chu. Gut microbial metabolism in ferroptosis and colorectal cancer. Trends in Cell Biology 2025; 35(4) doi: 10.1016/j.tcb.2024.08.006
|
| 15 |
Jiexia Wen, Huagang Liang, Min Zhao, Bin Xuan, Xiangcai Meng, Yang Liu, Liwei Wang, Li He, Tao Zhou, Yang Tao, Yimin Wang. Harnessing the gut microbiome to modulate ferroptosis: a metabolic strategy for the treatment of digestive tract cancers. Frontiers in Immunology 2025; 16 doi: 10.3389/fimmu.2025.1703964
|
| 16 |
Yuxuan Xia, Ting Sun, Mengjiao Zhou, Bo Wang, Fei Mao. HucMSC-derived exosomes alleviate inflammatory bowel disease via upregulating FXR to suppress macrophage ferroptosis. Biology Direct 2026; 21(1) doi: 10.1186/s13062-026-00820-5
|
| 17 |
Tianyu Han, Yan Jiang, Zhijun Liu, Lulu Wang, Yiding Liu, Shanshan Fei, Yu Yang, Tong Wang, Baiwen Guan, Mengran Cui, Qi Zhang, Haibin Wang, Guangliang Shi. Hyperoside improves intestinal mucosal immunity against zearalenone-induced intestinal barrier damage by regulating intestinal flora. Veterinary Immunology and Immunopathology 2025; 285 doi: 10.1016/j.vetimm.2025.110949
|
| 18 |
Nan Wu, Shuang Yu, Xiaoqi Wei, Lina Yang, Xiaowen Zhang. Multiple roles of bile acids in ferroptosis regulation: Opportunities for disease therapy. Pharmacological Research 2026; 228 doi: 10.1016/j.phrs.2026.108224
|
| 19 |
Xiangfei Xue, Manyuan Wang, Jiangtao Cui, Minying Yang, Lifang Ma, Rui Kang, Daolin Tang, Jiayi Wang. Glutathione metabolism in ferroptosis and cancer therapy. Cancer Letters 2025; 621 doi: 10.1016/j.canlet.2025.217697
|
| 20 |
Xiangxiang Wei, Yunquan He, Yueyang Yu, Sichong Tang, Ruiwen Liu, Jieyu Guo, Qingjun Jiang, Xiuling Zhi, Xinhong Wang, Dan Meng. The Multifaceted Roles of BACH1 in Disease: Implications for Biological Functions and Therapeutic Applications. Advanced Science 2025; 12(10) doi: 10.1002/advs.202412850
|
| 21 |
Zihan Shi, Shuyun Zhang, Hongru Zhai, Qingmin Wu, Yanyun Li, Huibin Xu, Shanlong Zhang. The interplay mechanisms between gut microbiota and ferroptosis in inflammatory bowel disease. Frontiers in Immunology 2026; 17 doi: 10.3389/fimmu.2026.1753617
|
| 22 |
Jiayin Fu, Fei Yan, Dong Qu, Longhua Wang, Xiaohua Chen, Guotao Pu, Wei Yin, Ching Yuan Hu. L-theanine combined with epigallocatechin gallate to ameliorate alcoholic liver disease in mice by regulating the intestinal flora and activating the PPARα/FABP1/GPX4 pathway to inhibit ferroptosis. Food Bioscience 2026; 83 doi: 10.1016/j.fbio.2026.109552
|
| 23 |
Tianyi Zhang, Chongjie Yao2, Xu Zhou, Shimin Liu, Li Qi, Shiguo Zhu, Chen Zhao, Dan Hu, Weidong Shen. Glutathione‑degrading enzymes in the complex landscape of tumors (Review). International Journal of Oncology 2024; 65(1) doi: 10.3892/ijo.2024.5660
|
| 24 |
Jingying Zhou, Penghui Lu, Haolong He, Ruhan Zhang, Dican Yang, Qiong Liu, Qianyan Liu, Mi Liu, Guoshan Zhang. The metabolites of gut microbiota: their role in ferroptosis in inflammatory bowel disease. European Journal of Medical Research 2025; 30(1) doi: 10.1186/s40001-025-02524-4
|